Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg/week: the RESETTLE trial

Introduction Childhood-onset obesity poses significant health risks, including early-onset type 2 diabetes, cardiovascular disease, and reduced quality of life. Hospital-based non-pharmacological obesity care can reduce childhood obesity, but 25% of children do not respond. Therefore, this study inv...

Descripción completa

Detalles Bibliográficos

Autores principales:	Torben Hansen, Simon Birk Kjær Jensen, Lærke Bruun Madsen, Jens-Christian Holm, Sarah Byberg, Joachim Holt, Rasmus Michael Sandsdal, Louise Aas Holm, Bodil Just Christensen, Signe Torekov
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 2024-11-01
Colección:	BMJ Open
Acceso en línea:	https://bmjopen.bmj.com/content/14/11/e082446.full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!